Janssen, Mitsubishi face lawsuits over kidney injuries from diabetes drug Invokana
October 4th, 2016
Janssen Pharmaceuticals and Mitsubishi Tanabe Pharma are facing dozens of lawsuits filed by patients who suffered kidney damage or other …
Tags: canagliflozin, diabetes, diabetic ketoacidosis, Invokana, Janssen Pharmaceuticals, kidney damage, MDL, Mitsubishi Tanabe Pharma, SGLT2 inhibitors
Posted in HO&P Legal Blog, Pharmaceutical Liability |